LDR (LDRH) Hits New Lifetime High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified LDR ( LDRH) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified LDR as such a stock due to the following factors:

  • LDRH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $11.9 million.
  • LDRH has traded 1,717 shares today.
  • LDRH is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in LDRH with the Ticky from Trade-Ideas. See the FREE profile for LDRH NOW at Trade-Ideas

More details on LDRH:

LDR Holding Corporation, a medical device company, focuses on designing and commercializing various surgical technologies for the treatment of patients suffering from spine disorders in the United States and internationally. Currently there are 6 analysts that rate LDR a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for LDR has been 222,200 shares per day over the past 30 days. LDR has a market cap of $1.1 billion and is part of the health care sector and health services industry. Shares are up 27.8% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com Analysis:

If you liked this article you might like

Perrenial Target and Acquirer NuVasive Names New President and COO

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

4 Medical Device Makers With Healthy-Looking Charts

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

LDR Holding (LDRH) Stock Downgraded at Barclays